Literature DB >> 15652726

The problem of psychogenic symptoms: is the psychiatric community in denial?

Selim R Benbadis1.   

Abstract

Psychogenic symptoms are common and pose an uncomfortable challenge. Among psychogenic symptoms, psychogenic nonepileptic seizures (PNES) are common and have been extensively studied. They are unique in that, unlike most other psychogenic symptoms, they can be diagnosed with near certainty. PNES can be used as a model, as almost everything that applies to PNES applies to other psychogenic symptoms. According to DSM-IV, somatic symptoms are the main manifestation of three groups of disorders: somatoform disorders, factitious disorder, and malingering. Treatment is challenging. Unfortunately, psychogenic symptoms tend to be neglected. For example, the American Psychiatric Association has abundant written patient education material available on diverse topics, but none on somatoform disorders. Psychogenic symptoms are also not the subject of much clinical research. A search of the journal Neurology for 1994-2003 for the word psychogenic in the title found 21 articles, only 4 of which on topics other than psychogenic seizures. A similar search for original articles in the New England Journal of Medicine found no articles with psychogenic in the title and two with psychogenic in the abstract. Thus, there seems to be a severe disconnect between the frequency of the problem and the amount of attention devoted to it.

Entities:  

Mesh:

Year:  2005        PMID: 15652726     DOI: 10.1016/j.yebeh.2004.10.009

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  13 in total

1.  [Negative response bias and the validity of personality profiles in neuropsychiatric assessment].

Authors:  T Merten; E Friedel; G Mehren; A Stevens
Journal:  Nervenarzt       Date:  2007-05       Impact factor: 1.214

Review 2.  The A, B, C's of factitious disorder: a response to Turner.

Authors:  James C Hamilton; Marc D Feldman; Jeffrey W Janata
Journal:  Medscape J Med       Date:  2009-01-27

3.  Neglected patients, few treatments, and minimal evidence: the updated cochrane review on psychological and behavioral treatments for nonepileptic seizures.

Authors:  Barbara A Dworetzky
Journal:  Epilepsy Curr       Date:  2014 Nov-Dec       Impact factor: 7.500

4.  Treatment Challenges in Nonepileptic Psychogenic Seizures: Finding the Perfect Fit for the No-One-Size-Fits-All Group.

Authors:  Roy Martin
Journal:  Epilepsy Curr       Date:  2017 May-Jun       Impact factor: 7.500

5.  Review-of-systems questionnaire as a predictive tool for psychogenic nonepileptic seizures.

Authors:  Liliana Robles; Sharon Chiang; Zulfi Haneef
Journal:  Epilepsy Behav       Date:  2015-03-23       Impact factor: 2.937

6.  Corticolimbic fast-tracking: enhanced multimodal integration in functional neurological disorder.

Authors:  Jorge Sepulcre; David L Perez; Ibai Diez; Laura Ortiz-Terán; Benjamin Williams; Rozita Jalilianhasanpour; Juan Pablo Ospina; Bradford C Dickerson; Matcheri S Keshavan; W Curt LaFrance
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-03-08       Impact factor: 10.154

Review 7.  A guide to disorders causing transient loss of consciousness: focus on syncope.

Authors:  J Gert van Dijk; Roland D Thijs; David G Benditt; Wouter Wieling
Journal:  Nat Rev Neurol       Date:  2009-07-14       Impact factor: 42.937

Review 8.  Long-term video EEG monitoring for diagnosis of psychogenic nonepileptic seizures.

Authors:  Evan R Gedzelman; Suzette M LaRoche
Journal:  Neuropsychiatr Dis Treat       Date:  2014-10-15       Impact factor: 2.570

9.  Risk factors for erectile dysfunction in patients with cardiovascular disease.

Authors:  Rakesh Kumar Chaudhary; Bilal Haider Shamsi; Hui-Ming Chen; Tan Tan; Kai-Fa Tang; Jun-Ping Xing
Journal:  J Int Med Res       Date:  2016-03-09       Impact factor: 1.671

10.  A Case of Dissociative Seizures Presented like Myoclonic Epilepsy.

Authors:  Balaswamy Reddy; Soumitra DAS; Mustafa Ali; Srinivas Guruprasad
Journal:  Shanghai Arch Psychiatry       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.